The business case for quality: combining medical literature research with health plan data to establish value for nonclinical managers.
Clinical managers face a growing need to communicate the value of what they do in terms that can be interpreted by nonclinical financial managers. We have sought to link the evidence basis of current guidelines to variables that will demonstrate in more financial terms the very real benefit of treating diseases aggressively. We have developed an approach using the medical literature that is designed to describe clinical initiatives in more concrete terms as desired by senior management. This becomes specifically critical during budget time and when justification for various clinical programs is needed. The approach uses medical research from the peer-reviewed literature to estimate the economic impact of various initiatives and then combines the analysis with an organization's actual data to impute potential benefit. A sample grid for developing the analysis is attached. A comprehensive bibliography that will assist others with similar endeavors has been included. Although not as rigorous as formal methods, actuarial analyses, or health services research activities, it presents a beginning framework around which an organization can create operational estimates of initiative effectiveness.
Fetterolf
Donald
D
Highmark Inc., Pittsburgh, PA 15222, USA. donald.fetterolf@highmark.com
West
Rebecca
R
D005376:Financial Management / Q000191:economics / Q000379:methods* / Q000458:organization & administration; D006801:Humans; D011785:Quality Assurance, Health Care / Q000191:economics / Q000458:organization & administration*; D012106:Research